Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

Daniel E. Spratt, Vinnie Y.T. Liu, Jeff Michalski, Elai Davicioni, Alejandro Berlin, Jeffry P. Simko, Jason A. Efstathiou, Phuoc T. Tran, Howard M. Sandler, William A. Hall, Darby J.S. Thompson, Matthew B. Parliament, Ian S. Dayes, Rohann Jonathan Mark Correa, John M. Robertson, Elizabeth M. Gore, Desiree E. Doncals, Eric Vigneault, Luis Souhami, Theodore G. KarrisonFelix Y. Feng

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science